News Conference News AHA 2015 Varenicline Helps ACS Patients Quit Smoking, But Effect Wanes Todd Neale November 12, 2015
News Conference News AHA 2015 IVUS Tops Angiography for Guiding DES Implantation in Long Lesions Todd Neale November 09, 2015
News Conference News AHA 2015 CANOA: Fewer Migraines With Clopidogrel Plus Aspirin Post-ASD Closure Shelley Wood November 08, 2015
News Conference News AHA 2014 Registry: Newer P2Y12 Inhibitors Reduce Stent Thrombosis, Mortality Over Clopidogrel Yael L. Maxwell November 17, 2014
News Conference News AHA 2014 Extending Clopidogrel Past 1 Year Improves Outcomes in DES, But Not BMS Patients Yael L. Maxwell November 16, 2014
News Conference News AHA 2014 DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation Yael L. Maxwell November 16, 2014
News Conference News AHA 2014 Long-Term Better than Short-Term Prasugrel After PES Stenting November 15, 2014
News Conference News AHA 2014 ITALIC Shows Noninferiority of 6-Month DAPT in Good Aspirin Responders Yael L. Maxwell November 15, 2014
News Conference News AHA 2014 ISAR-SAFE: Another Randomized Trial Finds 6 Months of DAPT as Good as 12 Months November 15, 2014
News Conference News AHA 2013 STREAM: Pre-hospital Fibrinolysis Strategy as Safe as Primary PCI at 1 Year in STEMI Yael L. Maxwell November 18, 2013
News Conference News AHA 2012 AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community Jason Kahn November 11, 2012
News Conference News AHA 2012 No Mortality Benefit with Prolonged Dual Antiplatelet Therapy November 05, 2012
News Conference News AHA 2012 TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes November 04, 2012
News Conference News AHA 2012 FREEDOM: CABG Superior to PCI in Diabetic Patients with Multivessel Disease November 04, 2012
News Conference News AHA 2012 ARCTIC: Bedside Platelet Monitoring Fails to Help DES Patients Jason Kahn November 04, 2012
News Conference News Higher Dosing Improves Clopidogrel Response in Carriers of Variant Genes November 16, 2011
News Conference News ‘Judicious Use’ of DES in Low-Risk Patients Could Save Over $200 Million per Year November 16, 2011
News Conference News ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients November 13, 2011
News Conference News AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab November 13, 2011